Continued efficacy of sulfadoxine-pyrimethamine as second line treatment for malaria in children in Guinea-Bissau

Acta Tropica

Volumn 100, Issue 3, 2006, Pages 213-217

  Kofoed, Poul Erik ^a,b,c   Rodrigues, Amabelia ^a   Aaby, Peter ^a,d   Rombo, Lars ^a,c,e,f  

^a Projecto de Saude de Bandim   (Guinea-Bissau)

^b KOLDING HOSPITAL   (Denmark)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF AARHUS   (Denmark)

^e Lab Nac da Saúde Pub   (Guinea-Bissau)

^f Division of Infectious Diseases Thoracic Medicine and Dermatology   (Sweden)

Author keywords

Children; Guinea Bissau; Malaria; Pyrimethamine; Retreatment; Sulfadoxine

Indexed keywords

AMODIAQUINE; CHLOROQUINE; FANSIDAR; QUININE;

ANTIMALARIAL AGENT; DISEASE RESISTANCE; DISEASE TREATMENT; DRUG RESISTANCE; GENETIC MARKER; MALARIA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL EXAMINATION; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FOLLOW UP; GENETIC MARKER; GUINEA-BISSAU; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ANIMALS; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DRUG COMBINATIONS; FEMALE; GUINEA-BISSAU; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; PARASITEMIA; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; SULFADOXINE; TABLETS; TREATMENT FAILURE; URBAN POPULATION;

AFRICA; GUINEA-BISSAU; SUB-SAHARAN AFRICA; WEST AFRICA;

PLASMODIUM FALCIPARUM;

EID: 33846590002     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actatropica.2006.09.014     Document Type: Article

References (21)

1. Bergqvist Y., Hjelm E., and Rombo L. Sulfadoxine assay using capillary blood samples dried on filter paper-suitable for monitoring of blood concentrations in the field. Ther. Drug Monit. 9 (1987) 203-207
2. Bwijo B., Kaneko A., Takechi M., Zungu I.L., Moriyama Y., Lum J.K., Tsukahara T., Mita T., Takahashi N., Bergqvist Y., Bjorkman A., and Kobayakawa T. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi. Acta Trop. 85 (2003) 363-373
3. Dorsey G., Vlahos J., Kamya M.R., Staedke S.G., and Rosenthal P.J. Prevention of increasing rates of treatment failure by combining sulfadoxine-pyrimethamine with artesunate or amodiaquine for the sequential treatment of malaria. J. Infect. Dis. 188 (2003) 1231-1238
4. Kachur S.P., Khatib R.A., Kaizer E., Fox S.S., Abdulla S.M., and Bloland P.B. Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania. Am. J. Trop. Med. Hyg. 71 (2004) 715-722
5. Kamya M.R., Bakyaita N.N., Talisuna A.O., Were W.M., and Staedke S.G. Increasing antimalarial drug resistance in Uganda and revision of the national drug policy. Trop. Med. Int. Health 7 (2002) 1031-1041
6. Kofoed P.E., Lopes F., Johansson P., Dias F., Sandstrom A., Aaby P., and Rombo L. Low-dose quinine for treatment of Plasmodium falciparum malaria in Guinea-Bissau. Trans. R. Soc. Trop. Med. Hyg. 93 (1999) 547-549
7. Kofoed P.E., Co F., Johansson P., Dias F., Cabral C., Hedegaard K., Aaby P., and Rombo L. Treatment of uncomplicated malaria in children in Guinea-Bissau with chloroquine, quinine, and sulfadoxine-pyrimethamine. Trans. R. Soc. Trop. Med. Hyg. 96 (2002) 304-309
8. Kofoed P.E., Lopez F., Johansson P., Sandstrom A., Hedegaard K., Aaby P., and Rombo L. Treatment of children with Plasmodium falciparum malaria with chloroquine in Guinea-Bissau. Am. J. Trop. Med. Hyg. 67 (2002) 28-31
9. Kofoed P.E., Alfrangis M., Poulsen A., Rodrigues A., Gjedde S.B., Ronn A., and Rombo L. Genetic markers of resistance to pyrimethamine and sulfonamides in Plasmodium falciparum parasites compared with the resistance patterns in isolates of Escherichia coli from the same children in Guinea-Bissau. Trop. Med. Int. Health 9 (2004) 171-177
10. Kublin J.G., Dzinjalamala F.K., Kamwendo D.D., Malkin E.M., Cortese J.F., Martino L.M., Mukadam R.A., Rogerson S.J., Lescano A.G., Molyneux M.E., Winstanley P.A., Chimpeni P., Taylor T.E., and Plowe C.V. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J. Infect. Dis. 185 (2002) 380-388
11. Muller O., van Hensbroek M.B., Jaffar S., Drakeley C., Okorie C., Joof D., Pinder M., and Greenwood B. A randomized trial of chloroquine, amodiaquine and pyrimethamine-sulphadoxine in Gambian children with uncomplicated malaria. Trop. Med. Int. Health 1 (1996) 124-132
12. Mutabingwa T., Nzila A., Mberu E., Nduati E., Winstanley P., Hills E., and Watkins W. Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania. Lancet 358 (2001) 1218-1223
13. Nagesha H.S., Din S., Casey G.J., Susanti A.I., Fryauff D.J., Reeder J.C., and Cowman A.F. Mutations in the pfmdr1, dhfr and dhps genes of Plasmodium falciparum are associated with in vivo drug resistance in West Papua, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 95 (2001) 43-49
14. Programa Nacional de Luta Contra o Paludismo, 2001. Política nacional de luta contra o paludismo. Bissau, Ministerio da Saúde Pública (Ref Type: Report).
15. Roche J., Guerra-Neira A., Raso J., and Benito A. Surveillance of in vivo resistance of Plasmodium falciparum to antimalarial drugs from 1992 to 1999 in Malabo (Equatorial Guinea). Am. J. Trop. Med. Hyg. 68 (2003) 598-601
16. Sendagire H., Kaddumukasa M., Ndagire D., Aguttu C., Nassejje M., Pettersson M., Swedberg G., and Kironde F. Rapid increase in resistance of Plasmodium falciparum to chloroquine-Fansidar in Uganda and the potential of amodiaquine-Fansidar as a better alternative. Acta Trop. 95 (2005) 172-182
17. The East African Network for monitoring Antimalarial Treatment. The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop. Med. Int. Health 8 (2003) 860-867
18. Wang P., Lee C.S., Bayoumi R., Djimde A., Doumbo O., Swedberg G., Dao L.D., Mshinda H., Tanner M., Watkins W.M., Sims P.F., and Hyde J.E. Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol. Biochem. Parasitol. 89 (1997) 161-177
19. World Health Organization, 2003. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparum malaria. WHO, Geneva (Ref Type: Report).
20. World Health Organization, 2006. RBMD. Global AMDP database-AFRO (Ref Type: Internet Communication).
21. World Health Organization, 2006. Roll Back Malaria Department. Global AMDP database-AFRO (http://www.who.int/malaria/amdp/amdp_afro.htm, accessed November 2005 and February 2006).